在GNAO1相关疾病中,护理人员对深度大脑刺激的观点和决策
Jana Domínguez-Carral1, Carola Reinhard2, Jane Yoo3
1Epilepsy Unit, Department of Child Neurology, Coordinating member of the ERN EpiCARE, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.
概括
护理人员认为深度大脑刺激 (DBS) 对于GNAO1相关疾病来说是拯救生命的,大大减少了危机并改善了生活质量. DBS的决定是复杂的,并且在情感上是沉重的,需要为家庭提供更好的支持和信息.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 医疗技术 医疗技术 医学技术
背景情况:
- 与GNAO1相关的障碍 (GNAO1-RD) 会导致严重的运动异常,如状态 dystonicus 和动力障碍危机.
- 深度大脑刺激 (DBS) 是这些衰弱条件的先进治疗选择.
- 追求DBS的决定涉及到受影响家庭的复杂的医疗,情感和后勤考虑.
研究的目的:
- 在GNAO1-RD.中探索护理人员对DBS决策过程的观点.
- 确定影响DBS的决定的关键因素.
- 了解与DBS治疗相关的家庭经历和挑战.
主要方法:
- 欧盟在接受DBS的基因确诊GNAO1-RD个体的护理人员中进行了一项调查.
- 收集的数据包括人口统计,临床特征,决策因素和术后经验.
- 定量数据进行了描述性分析,定性数据进行了主题分析.
主要成果:
- 共有12名护理人员参与了这项研究,DBS始于10.69岁的平均年龄.
- 对于DBS的主要征兆是状态 dystonicus 和动力障碍危机 (9/12),决策往往是紧急的 (9/12).
- 护理人员报告说,DBS后危机显著减少 (8/12),并将改善生活质量,减少住院治疗和外科医生的专业知识作为关键因素. 挑战包括手术前信息不足和情绪紧张.
结论:
- 护理人员认为DBS是GNAO1-RD的救生干预,有效地管理危机并提高生活质量.
- 对于DBS的决策过程是复杂的,对家庭来说是情感上的要求.
- 改善沟通,基于证据的指导和强有力的护理人员支持对于赋予家庭权力至关重要.
相关概念视频
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
Alzheimer's Disease: Overview
684
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
684
Parkinson's Disease: Overview
722
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
722
Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
1.7K
The nursing process provides a clinical decision-making framework for patients and families to establish and implement a personalized care plan. Since part of the nurse's duties is to teach patients, the steps of the nursing process are the most effective way to approach instruction. The nursing process and the teaching-learning process are inextricably linked.
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
1.7K


